![Zura Bio Ltd](/common/images/company/N_ZURA.png)
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutrali... Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.41 | -22.7777777778 | 1.8 | 2.06 | 1.35 | 331600 | 1.52113167 | CS |
4 | -0.56 | -28.7179487179 | 1.95 | 2.06 | 1.35 | 511938 | 1.71201068 | CS |
12 | -1.55 | -52.7210884354 | 2.94 | 3.18 | 1.35 | 543491 | 2.25646799 | CS |
26 | -2 | -58.9970501475 | 3.39 | 5.07 | 1.35 | 472682 | 3.19688588 | CS |
52 | -2.78 | -66.6666666667 | 4.17 | 6.35 | 1.35 | 383625 | 3.31447177 | CS |
156 | -6.61 | -82.625 | 8 | 37.55 | 1.35 | 364870 | 5.81102072 | CS |
260 | -6.61 | -82.625 | 8 | 37.55 | 1.35 | 364870 | 5.81102072 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.